Investor Relations

Pacific Biosciences' mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. The Company has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, Pacific Biosciences has created a powerful technology platform called single molecule, real-time, or SMRT™, technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform the understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

Recent News

May 1, 2012
Pacific Biosciences of California, Inc. Announces First Quarter 2012 Financial Results

MENLO PARK, Calif., May 1, 2012 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced financial results for the first quarter ended March 31, 2012. During t...


April 18, 2012
Pacific Biosciences of California, Inc. 1st Quarter 2012 Financial Results Call

MENLO PARK, Calif., April 18, 2012 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) will hold its quarterly conference call to discuss 1st Quarter 2012 financial results on Tu...


Stock Quote

NASDAQ (GM) : PACB
Price
$2.15
Last Trade
4:00 PM ET
May 16, 2012
Change
$-0.23
Change (%)
-9.664%
Volume
559,400
52 Week High
12.38
52 Week Low
2.25
Day High
2.42
Day Low
2.11

Investor
Contacts

Pacific Biosciences

1380 Willow Rd.
Menlo Park, CA 94025
(650) 521-8450
ir@pacificbiosciences.com